Scholarly Works

The Importance of Reporting Patient Recruitment...

Journal article

The Importance of Reporting Patient Recruitment Details in Phase III Trials

Authors

Wright JR; Bouma S; Dayes I; Sussman J; Simunovic MR; Levine MN; Whelan TJ

Journal

Journal of Clinical Oncology, Vol. 24, No. 6, pp. 843–845

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

February 20, 2006

DOI

10.1200/jco.2005.02.6005

ISSN

0732-183X

Associated Experts

Ian Stuart Dayes

Associate Professor, Faculty of Health Sciences

James Wright

Associate Professor, Faculty of Health Sciences

Jonathan Sussman

Professor, Faculty of Health Sciences

Mark Norman Levine

Professor Emeritus, Faculty of Health Sciences

Marko Simunovic

Professor, Faculty of Health Sciences

Timothy Whelan

Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Clinical Trials, Phase III as Topic Humans Patient Selection Research Design

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback